Global estimates on the number of persons across the Alzheimer's disease continuum

Cited by (900)

Items 101–200 of 900

  1. Harnessing Photo‐Energy Conversion in Nanomaterials for Precision Theranostics
    Jingyu Shi, Yadi Fan, Qin Zhang, Yingying Huang, Mo Yang · 2025 · Advanced Materials
  2. Hybrid Deep Learning Architecture with Adaptive Feature Fusion for Multi-Stage Alzheimer’s Disease Classification
    Ahmad Muhammad, Jin Qi, Osman Elwasila, Yonis Gulzar · 2025 · Brain Sciences
  3. Targeting the human gut microbiome: a comparative review of probiotics, prebiotics, synbiotics, and postbiotics
    Chunying Sun, Jingwen Zhu, Xueyuan Sun, Zhidong Zhang, Yantong Sun, Yan Jin, Tao Wu · 2025 · Journal of Advanced Research
  4. Independent study demonstrates amyloid probability score accurately indicates amyloid pathology
    Ilana Fogelman, Tim West, Joel B. Braunstein, Philip B. Verghese, Kristopher M. Kirmess, Matthew R. Meyer, John H. Contois, Eli Shobin, Kyle L. Ferber, Jake Gagnon et al. · 2023 · Annals of Clinical and Translational Neurology
  5. Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
    Mirjam Brackhan, Marina Arribas-Blázquez, Isabel Lastres‐Becker · 2023 · Antioxidants
  6. Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders
    Narges Naimi, Homa Seyedmirzaei, Zahra Hassannejad, Alireza Soltani Khaboushan · 2024 · Biomedicine & Pharmacotherapy
  7. Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
    Wang, Kang, Yang, Rongying, Li, Jing, Wang, Haitao, Wan, Li, He, Jiale · 2025 · Frontiers in Pharmacology
  8. Classifying Beta-Secretase 1 Inhibitor Activity for Alzheimer’s Drug Discovery with LightGBM
    Teuku Rizky Noviandy, Khairun Nisa, Ghalieb Mutig Idroes, Irsan Hardi, Novi Reandy Sasmita · 2024 · Journal of Computing Theories and Applications
  9. Disentangling clinical and biological trajectories of neurodegenerative diseases
    Nicolas Villain, Vincent Planche · 2024 · Nature Reviews Neurology
  10. ViTAD: Leveraging modified vision transformer for Alzheimer’s disease multi-stage classification from brain MRI scans
    Md. Ashif Mahmud Joy, Shamima Nasrin, Ayesha Siddiqua, Dewan Md. Farid · 2024 · Brain Research
  11. People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
    Karin E. Wahlberg, Bengt G. Winblad, Amanda Cole, William L. Herring, Joakim Ramsberg, Ilona Torontali, Pieter Jelle Visser, Anders B. Wimo, Lieve Wollaert, Linus Jönsson · 2023 · Journal of Internal Medicine
  12. Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer’s Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies
    Li, Sha, Lan, Xiaoyong, Liu, Yumei, Zhou, Junhong, Pei, Zian, Su, Xiaolin, Guo, Yi · 2024 · Journal of Alzheimer’s Disease
  13. Polysaccharides extracted from common buckwheat (Fagopyrum esculentum) attenuate cognitive impairment via suppressing RAGE/p38/NF-κB signaling and dysbiosis in AlCl3-treated rats
    Yu-Chen Liu, Sheng-Yi Chen, Ying-Ying Chen, Hsin‐Yu Chang, I‐Chen Chiang, Gow‐Chin Yen · 2024 · International Journal of Biological Macromolecules
  14. Beyond FITT: addressing density in understanding the dose–response relationships of physical activity with health—an example based on brain health
    Fabian Herold, Liye Zou, Paula Theobald, Patrick Manser, Ryan S. Falck, Qian Yu, Teresa Y L Liu-Ambrose, Charles H. Hillman, Arthur F. Kramer, Kirk I. Erickson et al. · 2025 · European Journal of Applied Physiology
  15. AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer’s Disease clinical trial
    Delshad Vaghari, Gayathri Mohankumar, Keith Tan, Andrew Lowe, Craig Shering, Peter Tiňo B, Zoe Kourtzi · 2025 · Nature Communications
  16. Donanemab for Alzheimer’s disease: from preclinical research to the clinical application
    Richard C. Dodel, Lutz Froelich · 2025 · Expert Review of Neurotherapeutics
  17. Alpiniae oxyphyllae fructus possesses neuroprotective effects on H2O2 stimulated PC12 cells via regulation of the PI3K/Akt signaling Pathway
    Ruolan Li, Lingyu Wang, Qing Zhang, Huxinyue Duan, Die Qian, Fei Yang, Jun Xia · 2022 · Frontiers in Pharmacology
  18. The Eye as a Diagnostic Tool for Alzheimer’s Disease
    Ahsan Hussain, Zahra Sheikh, Manju L. Subramanian · 2023 · Life
  19. Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
    Oliver Daniel Schreiner, Thomas Gabriel Schreiner · 2023 · Frontiers in Aging
  20. Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases
    Jiawen Shen, Xianping Wang, Minghui Wang, Hu Zhang · 2024 · Frontiers in Physiology
  21. Handwriting Changes in Alzheimer’s Disease: A Systematic Review
    C. Fernandes, Gemma Montalvo, Michael P. Caligiuri, Michael Pertsinakis, Joana Guimarães · 2023 · Journal of Alzheimer s Disease
  22. Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer’s Disease: A Recent Systematic Review
    Constantin Munteanu, Daniel Andrei Iordan, Mihail Hoteteu, Cristina Popescu, Ruxandra Luciana POSTOIU, Ilie Onu, Gelu Onose · 2023 · International Journal of Molecular Sciences
  23. Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease
    Natasha Azeelen Zulhafiz, Teow-Chong Teoh, Ai‐Vyrn Chin, Siow‐Wee Chang · 2025 · Computer Methods and Programs in Biomedicine
  24. Essential Oil Molecules Can Break the Loop of Oxidative Stress in Neurodegenerative Diseases
    Enzo Spisni, Maria Chiara Valerii, Maria Lina Massimino · 2023 · Biology
  25. Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?
    Roxanna Korologou‐Linden, Jatinderpal Kalsi, Dimitra Kafetsouli, Abdulwarrith Olawale, David Wingfield, David Mummery, Benedict W. J. Hayhoe, Oliver Robinson, Azeem Majeed, Lefkos T. Middleton · 2024 · The Journal of Prevention of Alzheimer s Disease
  26. Molecular Roles of NADPH Oxidase-Mediated Oxidative Stress in Alzheimer’s Disease: Isoform-Specific Contributions
    Junhyung Kim, Jong‐Seok Moon · 2024 · International Journal of Molecular Sciences
  27. Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer’s disease
    Manal Aljuhani, Azhaar Ashraf, Paul Edison · 2024 · Brain Communications
  28. Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
    Jianman Wang, Xing Lu, Yao He · 2025 · Biosensors
  29. Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders
    Jed W. Fahey, Hua Liu, Holly Batt, Anita A. Panjwani, Petra Akiko Tsuji · 2025 · Nutrients
  30. Early detection of Alzheimer’s disease progression stages using hybrid of CNN and transformer encoder models
    Hassan Almalki, Alaa O. Khadidos, Nawaf Alhebaishi, Ebrahim Mohammed Senan · 2025 · Scientific Reports
  31. Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial
    Susan R. Abushakra, Aidan Power, David Watson, Anton P. Porsteinsson, Marwan Sabbagh, Emer MacSweeney, Sharon Cohen, Merçé Boada, Pudugramam Murali Doraiswamy, Earvin Liang et al. · 2025 · Drugs
  32. Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
    Jordi Olloquequi, Miren Ettcheto, Amanda C. Cano, Ana C. Fortuna, Joana Bicker, Elena Sánchez‐López, Cristian Paz, Jesus Mariano Ureña, Ester Verdaguer, Carme Auladell et al. · 2023 · International Journal of Molecular Sciences
  33. The iceberg of dementia risk: empirical and conceptual arguments in favor of structural interventions for brain health
    Timothy P Daly · 2023 · Cerebral Circulation - Cognition and Behavior
  34. Essential role of sulfide oxidation in brain health and neurological disorders
    Eiki Kanemaru, Fumito Ichinose · 2024 · Pharmacology & Therapeutics
  35. Molecular Therapeutics in Development to Treat Alzheimer’s Disease
    Maria Carmela Tartaglia, Martin Ingelsson · 2024 · Molecular Diagnosis & Therapy
  36. Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases
    Monika A. Jakubowska, Vera Marisa Costa, Wojciech Krzeptowski, Pia Pužar Dominkuš, Marlene Santos, Birsen Can Demirdöğen, Şermin Genç, Ioannis P. Trougakos, Katja M. Kanninen, Brigitte M. Winklhofer‐Roob et al. · 2025 · Redox Biology
  37. High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in France
    Nicolas Villain, Vincent Planche, Richard Lévy · 2022 · Revue Neurologique
  38. Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians
    Pei‐Chuan Ho, Wai Haung Yu, Boon Lead Tee, Wan‐Ping Lee, Clara Li, Yian Gu, Jennifer S. Yokoyama, Dolly Reyes‐Dumeyer, Yun‐Beom Choi, Hyun‐Sik Yang et al. · 2024 · Alzheimer s & Dementia
  39. Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain
    Bindu Diana Paul, Andrew A. Pieper · 2024 · Biomolecules
  40. Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease
    Parisa Faraji, Hartmut Kühn, Shahin Ahmadian · 2024 · Journal of Molecular Neuroscience
  41. Detection of Mild Cognitive Impairment From Non-Semantic, Acoustic Voice Features: The Framingham Heart Study
    Huitong Ding, Adrian Lister, Cody Karjadi, Rhoda Au, Honghuang Lin, Brian Bischoff, Phillip H Hwang · 2024 · JMIR Aging
  42. Identification of 16 novel Alzheimer's disease loci using multi‐ancestry meta‐analyses
    Julian Willett, Mohammad Waqas, Younjung Choi, Tiffany Ngai, Kristina Mullin, Rudolph E. Tanzi, Dmitry Prokopenko · 2025 · Alzheimer s & Dementia
  43. A Novel Diagnostic Framework with an Optimized Ensemble of Vision Transformers and Convolutional Neural Networks for Enhanced Alzheimer’s Disease Detection in Medical Imaging
    Joy Chakra Bortty, Gouri Shankar Chakraborty, Inshad Rahman Noman, Salil Batra, Joy Das, Kanchon Kumar Bishnu, Md Tanvir Rahman Tarafder, Araf Islam · 2025 · Diagnostics
  44. The impact of real-world evidence in implementing and optimizing Alzheimer’s disease care
    Harald Juergen Hampel, Gang Li, Michelle M. Mielke, James E. Galvin, Miia Kivipelto, Emiliano Santarnecchi, Claudio Babiloni, Viswanath Devanarayan, Rifky Tkatch, Yan Ping Hu et al. · 2025 · Med
  45. Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis
    Maria Fernanda Serna-Orozco, Mildrey Mosquera, Herney Andrés García‐Perdomo · 2025 · NeuroMolecular Medicine
  46. Retinal biomarkers in cognitive impairment and dementia: Structural, functional, and molecular insights
    Min Yan, Hongyu Zhou, Zixiao Li, Yongjun Wang · 2025 · Alzheimer s & Dementia
  47. Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer’s disease
    Auwal Abdullahi, Thomson W. L. Wong, Shamay S. M. Ng · 2024 · Ageing Research Reviews
  48. Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
    Faiza Iram, Mohammad Shahid, Jaoud Ansari, Ghulam Md Ashraf, Md. Imtaiyaz Hassan, Asimul Islam · 2024 · Ageing Research Reviews
  49. Pharmacologic and Nutritional Interventions for Early Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Baoqi Zeng, Chunbian Tang, Junjian Wang, Qingqing Yang, Qingcuo Ren, Xiaozhi Liu · 2024 · Journal of Alzheimer s Disease
  50. Adult-onset deactivation of autophagy leads to loss of synapse homeostasis and cognitive impairment, with implications for alzheimer disease
    Hilary Grosso Jasutkar, Elizabeth M Wasserlein, Azeez Olakunle Ishola, Nicole A. Litt, Agnieszka Staniszewski, Ottavio Arancio, Ai Yamamoto · 2024 · Autophagy
  51. Microalgae and cyanobacteria as natural sources of antioxidant enzymes and enzyme inhibitors for Alzheimer's and diabetes
    Kilian Odenthal, Emmanuel Borges Nunes, Nuno Nunes, Tomásia Fernandes, Igor A. Fernandes, Miguel Â. A. Pinheiro de Carvalho · 2024 · Algal Research
  52. Analyzing alternative splicing in Alzheimer’s disease postmortem brain: a cell-level perspective
    Mohammad‐Erfan Farhadieh, Kamran Ghaedi · 2023 · Frontiers in Molecular Neuroscience
  53. Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real‐word study on aducanumab and lecanemab
    Giancarlo Logroscino, Daniele Urso, Valentina Gnoni, Alessia Giugno, Davide Vilella, A. Di Castri, Rita Maria Elisa Barone, Salvatore Lo Nigro, Chiara Zecca, Roberto De Blasi et al. · 2024 · European Journal of Neurology
  54. Non-Invasive Retinal Biomarkers for Early Diagnosis of Alzheimer’s Disease
    Snježana Kaštelan, Antonela Gverović Antunica, Velibor Puzović, Ana Didović Pavičić, Samir Čanović, Petra Kovačević, Pia Antonia Franciska Vučemilović, Suzana Konjevoda · 2025 · Biomedicines
  55. Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness
    Anja Hviid Simonsen, Helena Sophia Gleerup, Christian Sandøe Musaeus, Finn Thorup Sellebjerg, Malene Bredahl Hansen, Helle Bach Søndergaard, Gunhild Waldemar, Steen Gregers Hasselbalch · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  56. Recent Advances in Fluorescent Theranostics for Alzheimer’s Disease: A Comprehensive Survey on Design, Synthesis, and Properties
    Francisco, Telmo N., Malafaia, Daniela, Melo, Lúcia, Silva, Artur M. S., Albuquerque, Hélio M. T. · 2024 · ACS Omega
  57. Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases
    Emdormi Rymbai, Deepa Sugumar, Amritha Chakkittukandiyil, Ram Kothandan, Divakar Selvaraj · 2024 · Cell Biochemistry and Function
  58. Early detection of dementia using artificial intelligence and multimodal features with a focus on neuroimaging: A systematic literature review
    Ovidijus Grigas, R. Maskeliūnas, R. Damaševičius · 2024 · Health technology
  59. Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms
    Dongjoon Im, Tae Su Choi · 2024 · BMB Reports
  60. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
    Mikko Koivumäki, Laura L. Ekblad, Juan Lantero‐Rodriguez, Nicholas James Ashton, Thomas K. Karikari, Semi Helin, Riitta K Parkkola, Jyrki M. P. Lötjönen, Henrik Zetterberg, Kaj Blennow et al. · 2024 · Alzheimer s Research & Therapy
  61. A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer’s Disease
    William Burgess Grant · 2024 · Journal of Alzheimer s Disease
  62. Artificial General Intelligence for the Detection of Neurodegenerative Disorders
    Yazdan Ahmad Qadri, Khurshid Ahmad, Sung Won Kim · 2024 · Sensors
  63. Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer’s Disease
    Camillo Imbimbo, Matteo Cotta Ramusino, Silvia Leone, Federico Mazzacane, Valentino De Franco, Alberto Gatti, Giulia Perini, Alfredo Cardoso Costa · 2024 · CNS Drugs
  64. Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease
    Sandar Aye, Gunilla Johansson, Christoph Höck, Lars Lannfelt, John Randall Sims, Kaj Blennow, Kristian Steen Frederiksen, Caroline Graff, José Luís Molinuevo, Philip Scheltens et al. · 2025 · The Journal of Prevention of Alzheimer s Disease
  65. Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention
    Shari David, Ana Sofia Costa, Christian Hohenfeld, Sandro Romanzetti, Shahram Mirzazade, Jennifer Pahl, Luisa Haberl, Kai Markus Schneider, Axel Kilders, Thomas Eggermann et al. · 2025 · Journal of Alzheimer s Disease
  66. Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies
    Dittrich, Anna, Blennow, Kaj, Tan, Kübra, Benedet, Andrea L., Skoog, Ingmar, Höglund, Kina, Ashton, Nicholas J., Zetterberg, Henrik, Kern, Silke · 2025 · Alzheimer's & Dementia
  67. Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
    Victor James Drew, Chanung Wang, Tae Kim · 2023 · Frontiers in Aging Neuroscience
  68. Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers
    Ajith Mohan Arjun, Sudhaunsh Deshpande, Tom Dunlop, Beth Norman, Daniela Oliviera, Georgeta Vulpe, Felismina T.C. Moreira, Sanjiv Sharma · 2024 · Biosensors and Bioelectronics X
  69. REAL AD—Validation of a realistic screening approach for early Alzheimer's disease
    Antoine Leuzy, Fiona Heeman, Iris Bosch, Frida Lenér, Maria Greca Dottori, Kajsa Quitz, Alexis Moscoso, Silke Kern, Henrik Zetterberg, Kaj Blennow et al. · 2024 · Alzheimer s & Dementia
  70. Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review
    Sana Mohammadi, Sadegh Ghaderi, Farzad Fatehi · 2024 · Aging Medicine
  71. Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies
    Smita Jain, Ritu Singh, Tripti Paliwal, Kanika Verma, Jaya Dwivedi, Sarvesh Paliwal, Swapnil K. Sharma · 2024 · Pharmacology Biochemistry and Behavior
  72. Neuroprotective Effects of Cilomilast and Chlorogenic Acid Against Scopolamine-Induced Memory Deficits via Modulation of the cAMP/PKA–CREB–BDNF Pathway
    Esraa M. Mosalam, Soha Mohamed Atya, Noha M. Mesbah, Shady Allam, Eman T. Mehanna · 2025 · International Journal of Molecular Sciences
  73. “Real‐world” eligibility for anti‐amyloid treatment in a tertiary memory clinic setting
    Sinthujah Vigneswaran, Everard G.B. Vijverberg, Frederik Barkhof, Elsmarieke van de Giessen, Afina Willemina Lemstra, Yolande A.L. Pijnenburg, Charlotte Elisabeth Teunissen, Wiesje M. van der Flier, Argonde C. van Harten · 2025 · Alzheimer s & Dementia
  74. Intersection of H2S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases
    Priyanka Soni, Shravan Kumar Paswan, Bindu Diana Paul, Bobby Thomas · 2025 · Neurotherapeutics
  75. G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics
    Aditi Puri Singh, Sucharita Shadangi, Soumendra Rana · 2025 · Biochemical Pharmacology
  76. Quality of Life and the Experience of Living with Early-Stage Alzheimer’s Disease
    Alberto Villarejo‐Galende, Elena García-Arcelay, Gerard Piñol‐Ripoll, Antonio del Olmo-Rodríguez, Félix Viñuela, Merçé Boada, Emilio Franco Macías, Almudena Ibañez de la Peña, Mario Riverol, Albert Puig‐Pijoan et al. · 2022 · Journal of Alzheimer s Disease
  77. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer’s Disease
    Juan Fortea, Elena García-Arcelay, Ángeles Terrancle, Blanca Gálvez, Verónica Díez-Carreras, Pablo Rebollo, Jorge Mauriño, Guillermo García‐Ribas · 2023 · Journal of Alzheimer s Disease
  78. Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer’s disease
    Edmund Arthur, Swetha Ravichandran, Peter Jeffrey Snyder, Jessica Alber, Jennifer R. Strenger, Ava Katherine Bittner, Rima Khankan, Stephanie L. Adams, Nicole Putnam, Karin Rose Lypka et al. · 2023 · Alzheimer s Research & Therapy
  79. Identifying exercise and cognitive intervention parameters to optimize executive function in older adults with mild cognitive impairment and dementia: a systematic review and meta-analyses of randomized controlled trials
    Wenxin Chen, Jessie Siew-Pin Leuk, Yuhang Wu, Ning Huang, Wei‐Peng Teo · 2024 · European Review of Aging and Physical Activity
  80. Mathematical models on Alzheimer's disease and its treatment: A review
    Mitali Maji, Subhas Khajanchi · 2025 · Physics of Life Reviews
  81. Associations Between Glucose Metabolism Measures and Amyloid-β and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study
    Veerle van Gils, Qiushan Tao, Ting Fang Alvin Ang, Christina B. Young, Elizabeth C. Mormino, Wei Qiao Qiu, Pieter Jelle Visser, Rhoda Au, Willemijn J. Jansen, Stephanie J. B. Vos · 2024 · Diabetes Care
  82. The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer’s Disease
    Cristina A. Muñoz de León-López, Irene Navarro‐Lobato, Zafar U. Khan · 2025 · Biomolecules
  83. Sex and gender differences in dementia
    Patrick Salwierz, Carly Davenport, Vishaal Sumra, M. Florencia Iulita, Maria Teresa Ferretti, Maria Carmela Tartaglia · 2022 · International review of neurobiology
  84. Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation
    Michele Vendruscolo · 2023 · Expert Opinion on Drug Discovery
  85. Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment
    Ganesh Muneshwar Babulal, Ling Chen, Samantha A. Murphy, Jason M. Doherty, Ann M. Johnson, John C. Morris · 2023 · American Journal of Geriatric Psychiatry
  86. Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
    Songzhe Li, Zhitao Hou, Ting Ye, Xiaochen Song, Xinying Hu, Jing Chen · 2024 · Frontiers in Pharmacology
  87. Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor
    Keren Chen, Eunyoung Park, Khaled S. Abd‐Elrahman · 2025 · Molecular Pharmacology
  88. Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease
    Zhou, Can, Zeng, Fantian, Yang, Haijun, Liang, Zeying, Xu, Guanyu, Li, Xiao, Liu, Xingdang, Yang, Jian · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
  89. Characterization of the glymphatic system and early-phase β-amyloid imaging in Alzheimer's disease: A simultaneous PET/MR study
    Yuying Jiao, Wei Han, Linhan Zhang, Mengjiao Wang, Zhehao Lyu, Yexin Su, Zeyu Wang, Lifan Wang, Jiafu Wang, Peng Xu et al. · 2025 · Brain Research Bulletin
  90. Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline
    Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, Camillo Marra, Flavio Mariano Nobili, Lucilla Parnetti, Federica Agosta · 2023 · Journal of Neurology
  91. An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease
    Lydia A Piendel, Martin Vališ, Jakub Hort · 2023 · Frontiers in Aging Neuroscience
  92. Prognostic value of imaging-based ATN profiles in a memory clinic cohort
    Débora Elisa Peretti, Federica Ribaldi, Max Scheffler, Christian Chicherio, Giovanni Battista Frisoni, Valentina Garibotto · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
  93. Elettaria cardamomum (L.) Maton Essential Oil: An Interesting Source of Bioactive Specialized Metabolites as Inhibitors of Acetylcholinesterase and Butyrylcholinesterase
    Marta Pavarino, Arianna Marengo, Cecilia Cagliero, Carlo P. Bicchi, Patrizia Rubiolo, Barbara Sgorbini · 2023 · Plants
  94. Focusing on earlier diagnosis of Alzheimer's disease
    Kristian Steen Frederiksen, Xavier Morató, Henrik Zetterberg, Serge G. Gauthier, Merçé Boada, Vanesa Pytel, Julie Hviid Hahn-Pedersen, Luis Rafael Solís Tarazona, Soeren Mattke · 2024 · Future Neurology
  95. Causal effect of blood osteocalcin on the risk of Alzheimer’s disease and the mediating role of energy metabolism
    Xingzhi Guo, Yuying Yang, Rong Zhou, Ge Tian, Chang Shan, Jianmin Liu, Rui Li · 2024 · Translational Psychiatry
  96. MCNEL: A multi-scale convolutional network and ensemble learning for Alzheimer’s disease diagnosis
    Fei Yan, Lixing Peng, Fangyan Dong, Kaoru Hirota · 2025 · Computer Methods and Programs in Biomedicine
  97. RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
    Syed Arman Rabbani, Mohamed El‐Tanani, Shrestha Sharma, Yahia El‐Tanani, Rakesh Kumar, Manita Saini, Monu Yadav, Mohammad Ahmed Khan, Suhel Parvez · 2025 · European Journal of Neuroscience
  98. Electroencephalographic hallmarks of Alzheimer’s disease
    Florinda Ferreri, Francesca Miraglia, Fabrizio Vecchio, Nicoletta Manzo, Maria Cotelli, Elda Judica, Paolo Maria Rossini · 2022 · International Journal of Psychophysiology
  99. Nasal nanotherapeutics for central nervous system disorders: Bridging the translational gap in central nervous system drug delivery
    Yi-Bing Zhang, Mohan Liu, Yusi Wang, Die Hu, Siwen Wu, Binyan Zhao, Bailing Zhou, Li Yang · 2025 · European Journal of Pharmacology
  100. Precision medicine in neurodegeneration: the IHI-PROMINENT project
    Ashley Tate, Marc Suárez‐Calvet, Mats Ekelund, Sven Eriksson, Maria Eriksdotter, Wiesje M. van der Flier, Jean Georges, Miia Kivipelto, Milica Gregorič Kramberger, Peter Lindgren et al. · 2023 · Frontiers in Neurology